Lingman Ma
Impact in
- Microbiology top 2%
- Antimicrobial Peptides and Activities
- Pharmacology top 10%
- Flavonoids in Medical Research
- Microbial Natural Products and Biosynthesis
Papers in
- Microbiology 19
- Antimicrobial Peptides and Activities 18
- Oncology 8
- Pancreatic and Hepatic Oncology Research 3
- Drug Transport and Resistance Mechanisms 3
- Co-authors
- Changlin Zhou (28 shared papers)Zhaoshi Bai (12 shared papers)Yiran Zhou (6 shared papers)Baiyong Shen (3 shared papers)Meiling Jiang (6 shared papers)Hanhan Liu (4 shared papers)Pengfei Xu (5 shared papers)Ya Fang Huang (5 shared papers)
- Journals
- Peptides (3 papers)Cell Death and Disease (2 papers)Computational and Structural Biotechnology Journal (2 papers)Molecular and Cellular Endocrinology (1 paper)Microbiological Research (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Lingman Ma
46 papers receiving 856 citations
Lingman Ma's Hit Papers
Peers
Comparison fields: 5 of 84
- Microbiology 181
- Pharmacology 113
- Molecular Medicine 37
- Complementary and alternative medicine 35
- Drug Discovery 1
Countries citing papers authored by Lingman Ma
This map shows the geographic impact of Lingman Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingman Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingman Ma more than expected).
Fields of papers citing papers by Lingman Ma
This network shows the impact of papers produced by Lingman Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingman Ma. The network helps show where Lingman Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Lingman Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 111 | |
| 2 | 2019 | 89 | |
| 3 | 2020 | 57 | |
| 4 | 2016 | 54 | |
| 5 | 2019 | 47 | |
| 6 | A polyene macrolide targeting phospholipids in the fungal cell membrane Hit paper breakdown → | 2025 | 46 |
| 7 | 2020 | 39 | |
| 8 | 2020 | 39 | |
| 9 | 2018 | 36 | |
| 10 | 2023 | 31 | |
| 11 | 2017 | 24 | |
| 12 | 2017 | 24 | |
| 13 | 2019 | 20 | |
| 14 | 2021 | 18 | |
| 15 | 2019 | 17 | |
| 16 | 2021 | 17 | |
| 17 | 2022 | 16 | |
| 18 | 2017 | 15 | |
| 19 | 2018 | 15 | |
| 20 | 2019 | 15 |
About Lingman Ma
Lingman Ma is a scholar working on Microbiology, Oncology, Pharmacology, Epidemiology and Immunology, having authored 47 papers that have together received 867 indexed citations. Recurring topics across this work include Antimicrobial Peptides and Activities (18 papers), Influenza Virus Research Studies (4 papers), Pancreatic and Hepatic Oncology Research (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Flavonoids in Medical Research (3 papers), Antibiotic Resistance in Bacteria (3 papers), Microtubule and mitosis dynamics (2 papers) and Atherosclerosis and Cardiovascular Diseases (2 papers). The work is most often cited by research in Microbiology (181 citations), Pharmacology (113 citations), Molecular Medicine (37 citations), Complementary and alternative medicine (35 citations) and Drug Discovery (1 citation). Lingman Ma has collaborated with scholars based in China and United States. Frequent co-authors include Changlin Zhou, Zhaoshi Bai, Yiran Zhou, Baiyong Shen, Meiling Jiang, Hanhan Liu, Pengfei Xu, Ya Fang Huang, Qidi Ying and Qian Yu. Their work appears in journals such as Peptides, Cell Death and Disease, Computational and Structural Biotechnology Journal, Molecular and Cellular Endocrinology and Microbiological Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.